Keywords
Si Miao, Decoction, Acupuncture, Cupping
Si Miao, Decoction, Acupuncture, Cupping
Std= Standard; CRP= C-reactive protein; ESR= Erythrocyte sedimentation rate; SDM= standard difference in mean; Hg= hedge’s g; OR= odds ratio; SPDM= Standard paired difference; CORR= Correlation; CONSORT= Consolidated Standards of Reporting Trials; OSF= Center for Open Science; M-Si-M= Modified Si Miao; WM= Western medicine; WHO= World Health organization; M-Si-M+Ac+Cu= Ac=Si Miao Decoction combine with acupuncture and cupping therapy; Ac=Acupuncture; Cu= Cupping.
Arthritis is defined as the swelling of a joint that is accompanied by a limitation of motion, and increase in heat, pain, or tenderness1. Gout is a systemic disease which is also known as podagra and is caused by the presence of crystals of monosodium urate inside the tissues. These crystals trigger the inflammatory response that results in painful swelling mainly over the big toe2. Gouty arthritis can cause significant disability amongst patients that results in the dysfunction of normal self-care and recreational, social, and work activities3.
Gout is considered as one of the most prevalent inflammatory diseases. The general prevalence of gout is 1–4% of the general population4. It is affects people in different parts of the world including the UK (2.5% of the total population)5, Korea (1.94% per 1000 persons)6, and New-Zealand (2.69% Aotearoa New Zealand Health Tracker population)7.
Si Miao is the herbal combination of Cortex Phellodendri Chinensis, Rhizoma Atractylodis Lanceae, Radix Achyranthis Bidentatae, and Semen Coicis Lachryma-Jobi. It is also well known as the Four-Marvels Pill8. It is also available in a modified form with some additional herbs in actual formulation and has been used in the treatment of gout and arthritis. Acupuncture has been used to treat health conditions, including pain, for over 3,000 years, yet it has only been in the last half a century that biochemistry and neural imaging advances have allowed for the scientific understanding of its physiological mechanisms9. A number of studies have found the effectiveness of acupuncture in the treatment of gouty arthritis10,11. Lee, et al. have performed a systematic review on acupuncture for gouty arthritis and found it to be an effective complementary medicine12. Cupping therapy, commonly known as Al-hijamah in Islamic medicine, is also well-known amongst traditional practitioners in treating arthritis12–14.
Modified Si Miao San extract inhibits an inflammatory response and modulates insulin sensitivity in hepatocytes through an IKKβ/IRS-1/Akt-dependent pathway15. Acupuncture helps in reducing the pain and inflammation through an increase in IL-10 concentrations in the muscle16. Wet cupping helps to remove oxidants and reduce the oxidative stress through oxidative balance17. The imbalance of oxidative stress will result in an increase in the inflammatory response18.
A systematic literature search strategy was prepared according to the given guidelines by Cochrane infectious diseases19. Si Miao, Si Miao San, Si Miao Pian, Si Miao Wan, Gout and arthritis were the main keywords used during the search from different databases, such as PubMed, PubMed Central, and CNKI with the publication range being from 01 January 2010 till 31 August 2019. The literature works identified had been searched for in the English and Chinese languages. The list of keywords used in the English and Chinese versions have been mentioned in Table 1. The initial search syntax for PubMed and PubMed Central consisted of the following list.
1. (Si[All Fields] AND Miao[All Fields]) AND ("gout"[MeSH Terms] OR "gout"[All Fields]) AND ("2010/01/01"[PDAT] : "2019/08/31"[PDAT]); Si Miao[Text Word] AND Gout[Text Word] AND ("2010/01/01"[PubDate] : "2019/08/31"[PubDate])
2. (Si[All Fields] AND Miao[All Fields]) AND ("arthritis"[MeSH Terms] OR "arthritis"[All Fields]) AND ("2010/01/01"[PubDate] : "2019/08/31"[PubDate]); Si Miao[Text Word] AND arthritis[Text Word] AND ("2010/01/01"[PubDate] : "2019/08/31"[PubDate])
3. (Si[All Fields] AND Miao[All Fields] AND San[All Fields]) AND ("gout"[MeSH Terms] OR "gout"[All Fields]) AND ("2010/01/01"[PDAT] : "2019/08/31"[PDAT]); Si Miao San[Text Word] AND Gout[Text Word] AND ("2010/01/01"[PubDate] : "2019/08/31"[PubDate])
4. (Si[All Fields] AND Miao[All Fields] AND San[All Fields]) AND ("arthritis"[MeSH Terms] OR "arthritis"[All Fields]) AND ("2010/01/01"[PDAT] : "2019/08/31"[PDAT]); Si Miao San[Text Word] AND arthritis[Text Word] AND ("2010/01/01"[PubDate] : "2019/08/31"[PubDate])
5. (Si[All Fields] AND Miao[All Fields] AND Pian[All Fields]) AND ("gout"[MeSH Terms] OR "gout"[All Fields]) AND ("2010/01/01"[PDAT] : "2019/08/31"[PDAT]); (Si Miao Pian[Text Word]) AND gout[Text Word] AND (("2010/01/01"[PubDate] : "2019/08/31"[PubDate]))
6. (Si[All Fields] AND Miao[All Fields] AND Pian[All Fields]) AND ("arthritis"[MeSH Terms] OR "arthritis"[All Fields]) AND ("2010/01/01"[PDAT] : "2019/08/31"[PDAT]); (Si Miao Pian[Text Word]) AND arthritis[Text Word] AND (("2010/01/01"[PubDate] : "2019/08/31"[PubDate]))
7. (Si[All Fields] AND Miao[All Fields] AND Wan[All Fields]) AND gout[All Fields] AND ("2010/01/01"[PDAT] : "2019/08/31"[PDAT])
8. (Si[All Fields] AND Miao[All Fields] AND Wan[All Fields]) AND arthritis[All Fields] AND ("2010/01/01"[PDAT] : "2019/08/31"[PDAT])
A total number of 238 (n=238) articles were identified from different databases (PubMed, PubMed Central, and CNKI). The records were screened in two stages on the basis of number of duplications followed by some initial criteria where irrelevant articles, review articles, and animal and chemical studies had been excluded. After the initial screening, 132 (n=132) articles were identified. Microsoft Excel 201620 and Mendeley version 1.19.221 were used for data deduplication and citation management.
The included studies were based upon the use of the modified Si Miao (M-Si-M) combined with acupuncture and cupping for the treatment of gout and arthritis. The selected studies included both the Chinese and English languages but most of the studies available were in the Chinese language. The articles that focussed on the Si Miao formulation, modified Si Miao (M-Si-M) or combination of modified Si Miao (M-Si-M) with western medicine were excluded. After the application of the eligibility criteria, the number of articles had been reduced to six (n=6) articles and 126 articles (n=126) had been excluded. One article (n=1) had been removed further for qualitative synthesis and data extraction because of the absence of a randomised clinical trial (RCT). Clinical effectiveness, uric acid (UA), C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR) were accessed as the main outcome whereas the visual analogue Scale (VAS) and symptom scale had been excluded. Two articles (n=2) had been excluded because of unavailable outcome indicators which restrict the use to only three studies (n=3) for the meta-analysis. The flow chart of the study’s selection process according to the PRISMA flow diagram has been mentioned in Figure 1.
The Cochrane Handbook for Systematic Reviews of Interventions22 and JBI Systematic Reviews were used as reporting channels to assess the quality of the manuscript23. Two researchers independently evaluated the quality of the included studies, and a third party was consulted for resolution of any disagreement. The study design, participants, intervention, and outcome (SPIO) criteria have been mentioned in Table 2. The authors evaluated the methodological assessment under: aim/hypothesis clearly defined, adequate sample representation, patient care quality assurance, ethical approval protocol number, outcome clearly described, validity and reliability of outcome measure, attempt to blind researcher, follow-up, appropriate statistical analysis, and missing data reported (Figure 2). The bias assessment of the studies included in the qualitative synthesis included random sequence, allocation concealment, selective reporting, blinding of participants and personnel, blinding of outcome assessment, and incomplete outcome data according to the Cochrane guidelines (Table 3)22. The study characteristics of the selected studies were assessed according to the study design, treatment, control, statistical tool used, software to assess the outcome, and final outcome of the findings (Table 4). Uric acid, erythrocyte sedimentation rate, and C-reactive protein were the clinical parameters used after the treatment and further evaluation for the meta-analysis (Table 5). Microsoft Excel 201620 (Microsoft Corporation, Redmond, WA) was used to extract the data, removing study duplications, and Mendeley desktop 1.19.221 was used for importing the references.
Study and year | Random sequence generation | Allocation concealment | Selective reporting | Blinding of participants and personnel | Blinding of outcome assessment | Incomplete outcome data |
---|---|---|---|---|---|---|
Zhang, et al., 201924 | ||||||
Jia, et al., 201625 | ||||||
Chen, et al., 201526 | ||||||
Deng, et al., 201727 | ||||||
Yu, et al., 201328 |
Author, year | Study Design | Observed/ Treatment | Control | Statistical analysis | Software | Outcomes |
---|---|---|---|---|---|---|
Zhang, et al., 201924 | Randomized clinical trial | Acupuncture combined with modified Si Miao Powder | Western Medication | Chi-squared test | SPSS21.0 | VAS, Clinical effectiveness, CRP, ESR, UA |
Jia, et al., 201625 | Randomized clinical trial | Blood-letting combined with modified Si Miao Decoction | Western Medication | Chi-squared test | SPSS16.0 | VAS, Clinical effectiveness, WBC, ESR, CRP, UA |
Chen, et al., 201526 | Randomized clinical trial | Blood-letting combined with modified Si Miao Powder | Western Medication | t-test | SPSS17.0 | VAS, UA |
Deng, et al., 201727 | Randomized clinical trial | Blood-letting combined with Si Miao Powder | Western Medication | t-test | SPSS20.0 | VAS, Clinical effectiveness, UA, CRP, ESR |
Yu, et al., 201328 | Randomized clinical trial | Auricular Acupressure combined with Si Miao Powder | Western Medication | t-test | SPSS13.0 | VAS, Clinical Symptoms, UA |
Comprehensive Meta-Analysis (CMA) V2 software (Biostat, NJ) was used for data synthesis. Heterogeneity was quantitatively assessed using the I2 index. An I2 greater than 50% indicated significant heterogeneity amongst the studies. The results were expressed as mixed methods using both random and fixed effects. Effect sizes were expressed as odds ratio (OR), standard mean difference (SMD), Hedge’s g (HG), Standard paired difference (SPD), Correlation (C), and 95% confidence interval (CI). A Z score was calculated to determine the overall effect. Funnel plot analysis was used to evaluate the presence of publication bias. The extent of variation amongst the effects observed in different studies (between-study variance) is referred to as tau-squared, τ2, or Tau229.
Meta-analysis was conducted using the trial version of Comprehensive Meta-analysis (CMA) version 2.0 software30. A forest plot displaying the standard difference in mean, Hedge’s g, odds ratio, Standard paired difference, and Correlation 95% CIs for the impact of the observed therapy versus the control on different parameters were observed. True heterogeneity amongst the trials was assessed using the tau, T231, and the extent of the inconsistency was measured by the I2 index32.
All the included studies employed clinical effect as the outcome assessment. The clinical parameters included CRP, ESR, and uric acid concentration after treatment with the modified Si Miao decoction combined with acupuncture and cupping therapy. The cumulative effect was observed by the meta-analysis of three randomised clinical treatment arms that suggested a significant reduction in the clinical parameters using the modified Si Miao decoction combined with acupuncture and cupping therapy (SMD: −0.91,95% CI: −1.081, −0.741, p = 0.000) (OR: −1.652, 95% CI: −1.960, −1.344, p = 0.000). The forest plot, funnel plot of Cumulative std difference in means, and Log odds ratio of the Si Miao decoction combined with acupuncture and cupping therapy versus the Control have been expressed in the Extended data (Figures 3 and Figure 4), respectively. A high heterogeneity test was indicated (Q=146.548, P = 0.00, I2 = 94.54%) (Extended data: Figure 5). The estimated between-study variances of the cumulative Log odds ratio of the Si Miao decoction combined with acupuncture and cupping therapy versus the Control were tau= 1.974, Tau-squared = 3.897 with a standard error= 2.129, and variance= 4.533 (Extended data: Figure 5). The estimated between-study variances of the cumulative standard difference in means of the Si Miao decoction combined with acupuncture and cupping therapy versus the Control were tau= 1.088, Tau-squared = 1.184 with a standard error= 0.647, and variance= 0.419 (Extended data: Figure 6).
Three studies measured blood uric acid as the outcome; a comparison between the observed versus the Control post-treatment was calculated. Data extracted from the three individual studies showed that heterogeneity existed (Q=34.154, P = 0.000, I2 = 94.144%; Extended data: Figure 7). The fixed and random effects model was utilised for the statistical analysis. The estimated between-study variances of the std difference in the mean of the Si Miao decoction combined with acupuncture and cupping therapy versus the Control were tau= 1.042, Tau-squared = 1.085 with a standard error= 1.163, and variance= 1.353 (Extended data: Figure 7). The data suggested that the Si Miao decoction combined with acupuncture and cupping therapy could further decrease uric acid as compared to the control (SDM -0.960; 95% CI -1.240, -0.660; P < 0.000) (Hg -0.940; 95% CI -1.227, -0.652; P < 0.000) (OR 0.179; 95% CI 0.105, 0.302; P < 0.000) (SPDM -0.950; 95% CI -1.240, -0.660; P < 0.000) (CORR -0.513; 95% CI -0.597, -0.417; P < 0.000) (Extended data: Figure 8). The funnel plot displaying the (A) standard difference in mean, (B) Hedge’s g, (C) odds ratio, (D) Standard paired difference, and (E) Correlation 95% CIs for the impact of the observed therapy versus the Control on the uric acid concentrations have been represented in Extended data (Figure 9).
Three studies measured blood Erythrocyte Sedimentation Rate (ESR) as the outcome; a comparison between the observed versus the Control post-treatment was calculated. The data extracted from the three individual studies showed that heterogeneity existed (Q=12.092, P = 0.002, I2 = 83.460%; Extended data: Figure 7). Fixed and random effects models were utilised for the statistical analysis. The estimated between-study variances of the std difference in the mean of the Si Miao decoction combined with acupuncture and cupping therapy versus the Control were tau= 0.556, Tau-squared = 0.310 with a standard error= 0.372, and variance= 0.139 (Extended data: Figure 7). The data suggested that the Si Miao decoction combined with acupuncture and cupping therapy could further decrease the ESR as compared to the Control (SDM -0.808; 95% CI -1.087, 0.530; P < 0.000) (Hg -0800; 95% CI -1.076, -0.524; P < 0.000) (OR 0.231; 95% CI 0.139, 0.383; P < 0.000) (SPDM -0.808; 95% CI -1.087, 0.530; P < 0.000) (CORR -0.400; 95% CI -0.500, -0.289; P < 0.000) (Extended data: Figure 10). The funnel plot displaying the (A) standard difference in mean, (B) Hedge’s g, (C) odds ratio, (D) Standard paired difference, and (E) Correlation 95% CIs for the impact of the observed therapy versus the Control on the uric acid concentrations have been represented in the Extended data (Figure 11).
Three studies measured blood C-Reactive Protein (CRP) as the outcome; a comparison between the observed versus the Control post-treatment was calculated. The data extracted from the three individual studies showed that heterogeneity existed (Q=99.391, P = 0.000, I2 = 97.988%; Extended data: Figure 7). Fixed and random effects models were utilised for the statistical analysis. The estimated between-study variances of the std difference in the mean of the Si Miao decoction combined with acupuncture and cupping therapy versus the Control were tau= 2.056, Tau-squared = 4.228 with a standard error= 4.483, and variance= 20.099 (Extended data: Figure 7). The data suggested that the Si Miao decoction combined with acupuncture and cupping therapy could further decrease the CRP as compared to the Control (SDM -3.892; 95% CI -4.637, -3.146; P < 0.000) (Hg -0.940; 95% CI -1.227, -0.652; P < 0.000) (OR 0.179; 95% CI 0.105, 0.302; P < 0.000) (SPDM -0.950; 95% CI -1.240, -0.660; P < 0.000) (CORR -0.513; 95% CI -0.597, -0.417; P < 0.000) (Extended data: Figure 12). The funnel plot displaying the (A) standard difference in mean, (B) Hedge’s g, (C) odds ratio, (D) Standard paired difference, and (E) Correlation 95% CIs for the impact of the observed therapy versus the Control on theuric acid concentrations have been represented in Extended data (Figure 13).
Five studies were included for methodological assessment and inconsistencies were found in the methodology. Yu, et al. (2013)28 was the only study in compliance with the key indicators for the methodological assessment followed by Deng, et al. (2017)27. The Cochrane bias assessment also validated the results produced from the methodological assessment with most of the indicators being unclear and reporting of high risk of bias in random sequencing generation and blinding of the outcome assessment in Deng, et al. (2017)27. Three (n=3) studies were considered for meta-analysis because the other two (n=2) studies were unable to comply with the eligibility criteria. This research has focused on comparing the randomised clinical trial of studies consisting of the combination of the Modified Si Miao (M-Si-M) with acupuncture (Ac) and cupping (Cu) treatment (M-Si-M+Ac+Cu) against that of western medicine. The clinical parameters of uric acid (UA)33, Erythrocyte sedimentation rate (ESR), and C-Reactive protein (CRP) are important indicators in the treatment of arthritis and gout34. The combination of the Modified Si Miao (M-Si-M) with acupuncture (Ac) and cupping (Cu) treatment was found to be better as compared with the western medicine (WM) but high heterogeneity was observed amongst all of the clinical parameters. High heterogeneity was observed because of methodological issues, such as problems with randomisation, early termination of trials, use of absolute rather than relative measures of risk, and publication bias35. An improvement in the symptoms was observed when compared between the two treatments without any adverse effects.
This review is the first systematic review comparing the modified Si Miao decoction combined with acupuncture and cupping therapy (M-Si-M+Ac+Cu) against western medicine. There were a few limitations of this study, such as small sample size, lack of available research, and that most of the articles were published in China. Language was another barrier to report in this research as most the articles had been published in the Chinese language. There was also a high uncertainty in the methodology that led to publication bias. This evidence had been supported and verified in another systematic review on cupping therapy versus acupuncture for pain‑related conditions36. Further research on the same formulation is recommended with an improved clinical protocol using Consolidated Standards of Reporting Trials (CONSORT)37. It is also recommended to register the protocol with ClinicalTrials.gov38, Trial Registration by WHO39 or ISRCTN registry40. To increase the transparency and openness in the research, Science Europe40 launched plan S40 on 4 September 2018 that acknowledged the implementation of open archives and repositories to all journals. Therefore, it is recommended to increase the openness, integrity, and reproducibility of scientific research using the Centre for Open Science (OSF)41.
All data underlying the results are available as part of the article and no additional source data are required.
Open Science Framework: Analysis of Clinical efficacy of Si Miao decoction combine with Acupuncture and Cupping treatment for Gout: A systematic review and meta-analysis, https://doi.org/10.17605/OSF.IO/PUCX642.
This project contains the following extended data:
- Figure 3: (A) Forest plot of Si Miao decoction combine with acupuncture and cupping therapy versus Control: cumulative std difference in means (B) Funnel plot of Si Miao decoction combine with acupuncture and cupping therapy versus Control: cumulative std difference in means
- Figure 4: (A) Forest plot of Si Miao Decoction combine with acupuncture and cupping therapy versus Control: Log odds ratio (B) Funnel plot of Si Miao Decoction combine with acupuncture and cupping therapy versus Control: Log odds ratio
- Figure 5: Heterogeneity and tau squared cumulative Log odds ratio of Si Miao Decoction combine with acupuncture and cupping therapy versus Control
- Figure 6: Heterogeneity and tau squared cumulative std difference in means of Si Miao Decoction combine with acupuncture and cupping therapy versus Control
- Figure 7: Heterogeneity and tau squared std difference in means of Si Miao Decoction combine with acupuncture and cupping therapy versus Control on outcomes parameters (A) ESR (B) CRP (C) Uric Acid
- Figure 8: Forest plot displaying (A) standard difference in mean for the impact of observed therapy versus control on uric acid concentrations. (B) Hedge’s g for the impact of observed therapy versus control on uric acid concentrations. (C) Odds ratio for the impact of observed therapy versus control on uric acid concentrations. (D) Standard paired difference for the impact of observed therapy versus control on uric acid concentrations. (E) Correlation 95 % CIs for the impact of observed therapy versus control on uric acid concentrations.
- Figure 9: Funnel plot displaying (A) Standard difference in mean for the impact of observed therapy versus control on uric acid concentrations. (B) Hedge’s g for the impact of observed therapy versus control on uric acid concentrations. (C) Odds ratio for the impact of observed therapy versus control on uric acid concentrations. (D) Standard paired difference for the impact of observed therapy versus control on uric acid concentrations. (E) Correlation 95 % CIs for the impact of observed therapy versus control on uric acid concentrations.
- Figure 10: Forest plot displaying (A) Standard difference in mean for the impact of observed therapy versus control on ESR concentrations. (B) Hedges’ g for the impact of observed therapy versus control on ESR concentrations. (C) Odds ratio for the impact of observed therapy versus control on ESR concentrations. (D) Standard paired difference for the impact of observed therapy versus control on ESR concentrations. (E) Correlation 95 % CIs for the impact of observed therapy versus control on ESR concentrations.
- Figure 11: Funnel plot displaying (A) Standard difference in mean for the impact of observed therapy versus control on ESR concentrations. (B) Hedge’s g for the impact of observed therapy versus control on ESR concentrations. (C) Odds ratio for the impact of observed therapy versus control on ESR concentrations. (D) Standard paired difference for the impact of observed therapy versus control on ESR concentrations. (E) Correlation 95 % CIs for the impact of observed therapy versus control on ESR concentrations.
- Figure 12: Forest plot displaying (A) Standard difference in mean for the impact of observed therapy versus control on CRP concentrations. (B) Hedge’s g for the impact of observed therapy versus control on CRP concentrations. (C) Odds ratio for the impact of observed therapy versus control on CRP concentrations. (D) Standard paired difference for the impact of observed therapy versus control on CRP concentrations. (E) Correlation 95 % CIs for the impact of observed therapy versus control on CRP concentrations.
- Figure 13: Funnel plot displaying (A) Standard difference in mean for the impact of observed therapy versus control on CRP concentrations. (B) Hedge’s g for the impact of observed therapy versus control on CRP concentrations. (C) Odds ratio for the impact of observed therapy versus control on CRP concentrations. (D) Standard paired difference for the impact of observed therapy versus control on CRP concentrations. (E) Correlation 95 % CIs for the impact of observed therapy versus control on CRP concentrations.
Open Science Framework: PRISMA checklist for ‘Analysis of clinical efficacy of Si Miao decoction combine with acupuncture and cupping treatment for gout: a systematic review and meta-analysis’, https://doi.org/10.17605/OSF.IO/PUCX642.
Data are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).
Special thanks to Aishah Rose Marie for her perseverance in proofreading the manuscript.
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Are the rationale for, and objectives of, the Systematic Review clearly stated?
Yes
Are sufficient details of the methods and analysis provided to allow replication by others?
Partly
Is the statistical analysis and its interpretation appropriate?
Partly
Are the conclusions drawn adequately supported by the results presented in the review?
Partly
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: traditional Chindese medicine and acupuncture
Are the rationale for, and objectives of, the Systematic Review clearly stated?
Yes
Are sufficient details of the methods and analysis provided to allow replication by others?
Yes
Is the statistical analysis and its interpretation appropriate?
Partly
Are the conclusions drawn adequately supported by the results presented in the review?
Partly
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Traditional Medicine (eastern asian).
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | ||
---|---|---|
1 | 2 | |
Version 1 03 Mar 21 |
read | read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)